- cafead   Nov 04, 2021 at 10:22: AM
via
article source
- Pfizer delivered outstanding results in the third quarter with strong revenue and earnings growth.
- The most important detail, though, in Pfizer's Q3 update was its forecast for 2022 COVID-19 vaccine sales.
- Pfizer's Comirnaty guidance for 2022 is key because it sets a realistic expectation for investors.
article source